首页> 美国卫生研究院文献>Thorax >Specific IgG subclass antibody pattern toAspergillus fumigatus in patients withcystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)
【2h】

Specific IgG subclass antibody pattern toAspergillus fumigatus in patients withcystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)

机译:特异的IgG亚类抗体模式烟曲霉患者囊性纤维化伴过敏性支气管肺曲菌病(ABPA)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BACKGROUND—IgG and IgG subclass antibodies to Aspergillus fumigatus (A fumigatus) were measured in a large population of patients with cystic fibrosis to elucidate a putative antibody pattern specific for allergic bronchopulmonary aspergillosis (ABPA).
METHODS—An ELISA technique using water soluble somatic hyphal (WSSH) A fumigatus antigens and subclass specific monoclonal antibodies was used for cross sectional quantification of IgG and IgG1-4 subclass antibody levels in the serum of 238 patients with cystic fibrosis and 107 healthy controls.
RESULTS—In patients with cystic fibrosis persistently colonised with A fumigatus the subclass antibody levels were significantly increased compared with patients with cystic fibrosis never or rarely colonised (p<0.001). The group of patients persistently colonised with A fumigatus with ABPA (+Af+ABPA) had significantly increased levels of IgG antibodies to A fumigatus (Af-IgG) (median 69 ELISA units (EU) versus 31) and of subclasses Af-IgG1 (91 versus 27), Af-IgG2 (143 versus 56), and Af-IgG4 antibodies (72 versus 20), but not of IgG3 (17 versus 15), compared with the colonised patients without ABPA (+Af-ABPA). Patients with cystic fibrosis withno or only rare isolates of A fumigatuswithout ABPA (-Af-ABPA) also had significantly increasedsubclass antibody levels (Af-IgG1 9 versus 3, Af-IgG2 28 versus 5, Af-IgG4 16 versus 4;p<0.001) compared with healthy controls. Low, although detectable,levels of antibodies were demonstrated in healthy controls. ABPA seemedto occur independently of Pseudomonas aeruginosainfection. Using diagnostic cut off levels for ABPA, sensitivityand specificity were calculated. The highest specificity was found forIgG4 (88%); sensitivity was between 65% and 73%. Thepositive predictive values (PPV) were moderate, whereas the negativepredictive values (NPV) were high (96% in all subclasses exceptIgG3 with 94%). PPV increased to 50% if IgG1as well as IgG2 and IgG4 were included.
CONCLUSIONS—In a largenumber of unselected patients with cystic fibrosis significantlyincreased levels of Af-specific antibodies belonging to total IgG andall four subclasses were found in all groups of patients compared withhealthy controls. In patients persistently colonised withA fumigatus these levels were significantlyhigher than in non-colonised patients, and the significantly highest levels (with the exception of IgG3) were found in patientswith ABPA. Using a sensitive ELISA technique, measurements of IgG and IgG subclass antibodies to A fumigatus mightbe of importance in the management of ABPA, especially as a screeningtest to exclude the presence of ABPA; other tests are needed to confirmthe diagnosis.

机译:背景技术在许多患有囊性纤维化的患者中测量了烟曲霉(Afumigatus)的IgG和IgG亚类抗体,以阐明对过敏性支气管肺曲菌病(ABPA)特异的推定抗体模式。
方法:一种使用ELISA技术的方法水溶性体细胞菌丝(WSSH)烟熏抗原和亚类特异性单克隆抗体被用于横断面定量分析238例囊性纤维化患者和107例健康对照者血清中IgG和IgG1-4亚类抗体的水平。
结果—与从未或很少定植的囊性纤维化患者相比,在烟曲霉持续存在的囊性纤维化患者中,亚类抗体水平显着升高(p <0.001)。持续感染ABPA烟熏菌(+ Af + ABPA)的患者组中,针对烟熏菌(Af-IgG)的IgG抗体水平显着升高(中位ELISA单位为69个(EU),而31个为中值)以及Af-IgG1亚类(与没有ABPA(+ Af-ABPA)的定植患者相比,Af-IgG2(143对56)和Af-IgG4抗体(72对20),而IgG3抗体则没有(17对15)。囊性纤维化患者没有或只有罕见的烟熏分离株没有ABPA(-Af-ABPA)也有明显增加亚类抗体水平(Af-IgG1 9对3,Af-IgG2 28对5,Af-IgG4 16对4;与健康对照相比p <0.001)。低,虽然可以检测到在健康对照中证明了抗体的水平。 ABPA似乎独立于铜绿假单胞菌发生感染。使用ABPA的诊断截止水平,灵敏度和特异性进行了计算。发现最高的特异性IgG4(88%);敏感性在65%至73%之间。的阳性预测值(PPV)为中等,而阴性为预测值(NPV)高(除所有子类中的96%外,IgG3(94%)。如果IgG1,PPV可提高到50%以及IgG2和IgG4。
结论—未选择的囊性纤维化患者数属于总IgG的Af特异性抗体水平增加与所有患者组相比,所有四个亚类都被发现健康对照。在患者持续定植于烟气这些水平显着高于非殖民化患者,并且在患者中发现了最高的水平(IgG3除外)与ABPA。使用灵敏的ELISA技术,可能会对烟曲霉的IgG和IgG亚类抗体进行测量在ABPA的管理中非常重要,尤其是作为筛查测试以排除ABPA的存在;需要其他测试以确认诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号